EP Patent

EP2327692B1 — 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2012-07-18 · 14y expired

What this patent protects

Patent listed against vonoprazan-fumarate.

Drugs covered by this patent

vonoprazan-fumarate (VONOPRAZAN FUMARATE)

Patent Metadata

Patent number: EP2327692B1
Jurisdiction: EP
Classification: —
Expires: 2012-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Takeda Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.